Vaccines Against Infectious Diseases and Cancers

Vaccines against infectious diseases represent a therapeutic vaccine against chronic infectious diseases aim at eliciting broad humoral and cellular immune responses against multiple target antigens. The development of these vaccines will help to establish substitute markers of protection in humans and thus will boost the subsequent development of capable prophylactic vaccines. A grouping of synthetic small-molecule drugs and immunotherapeutics is likely to represent a powerful means of controlling chronic infections in the future. There are a number of scientific challenges which require multidisciplinary teams to solve problems in developing new immunogens. This has challenged our existing knowledge about protein structure and conformation, microbial pathogenicity and the immune system. Cancer cells are generally ignored by the immune system. This is because for the most of the part are more closely resemble cells that belong in the body than pathogens, such as bacterial cells or viruses. The goal of cancer vaccines is to provoke the immune system to identify cancer cells as foreign and attack them.

Vaccines against infectious diseases represent a therapeutic vaccine against chronic infectious diseases aim at eliciting broad humoral and cellular immune responses against multiple target antigens. The development of these vaccines will help to establish substitute markers of protection in humans and thus will boost the subsequent development of capable prophylactic vaccines. A grouping of synthetic small-molecule drugs and immunotherapeutics is likely to represent a powerful means of controlling chronic infections in the future. There are a number of scientific challenges which require multidisciplinary teams to solve problems in developing new immunogens. This has challenged our existing knowledge about protein structure and conformation, microbial pathogenicity and the immune system. 

 

  • Adenoviral Vectors for Mucosal Vaccination Against Infectious Diseases
  • Challenges in Mucosal Vaccines for the Control of Infectious Diseases
  • Plant based Mucosal Vaccines Against Widespread Infectious Dseases
  • Mucosal Immunization for Cancer Opportunities and Challenges
  • Mucosal Cancer Vaccines
  • Attenuated Viral Vaccines for Mucosal Immunity to Combat Emerging Infectious Diseases
  • Biomarkers in Vaccines
  • Chickenpox Vaccine
  • Mucosal Delivery to Improve Cancer Vaccine Efficacy
  • Mucosal Delivery of Particulate Breast Cancer Vaccine
  • H1N1 Vaccine
  • OPV Vaccine
  • Rubella Vaccine
  • Pneumonia Vaccines
  • Cancer Therapeutic Vaccines
  • Vaccines to Prevent Measles

Related Conference of Vaccines Against Infectious Diseases and Cancers

October 29-30, 2018

6th International Conference on HIV/AIDS, STDs and STIs

San Francisco, USA
November 26-27, 2018

3rd International Conference on Autoimmunity

Dublin, Ireland (Louis Fitzgerald Hotel)
December 05-06, 2018 | Lisbon, Portugal

Global Meet on Immunology, Hematology & Molecular Biology

Holiday Inn Lisbon - Continental, R. Laura Alves 9, 1069-169 Lisboa, Portugal
December 06-08, 2018

Annual Congress on Antibiotics and Antimicrobial Resistance

Amsterdam, Netherlands
February 22-23, 2019

World Congress on Immunity and Immuno Therapies

Dallas, Texas, USA
March 04-05, 2019

10th Molecular Immunology & Immunogenetics Congress

Barcelona, Spain
March 17-18, 2019

International Congress on Autoimmunity

Brisbane, Australia
March 18-19, 2019

11th Global Summit on Immunology and Cell Biology

Sydney, Australia
June 13-14, 2019 |

10th European Immunology Conference

Berlin, Germany
July 19-20, 2019

8th International Conference on Clinical Trials

| Atlanta, USA
October 21-22, 2019

12th Annual Congress on Immunology & Immunogenetics

Rome, Italy
November 22-23, 2019 |

World Conference on Vaccine and Immunology

Dubai, UAE

Vaccines Against Infectious Diseases and Cancers Conference Speakers

Recommended Sessions

Related Journals

Are you interested in